Issuer · CIK 0001826457
GLUE — Monte Rosa Therapeutics, Inc.
⚡ SELL CLUSTER · last 7 days
2 insiders sold $98.3K of $GLUE on Jun 18, 2026.
Cluster patterns historically carry stronger directional signal than any single insider trade. Read the methodology →
Champoux Jennifer
Chief Operating Officer
$41.3K
Jun 18, 2026
Townson Sharon
Chief Scientific Officer
$57K
Jun 18, 2026
Recent filings
- Jun 18, 2026·Form 4·Sell$41.3K
GLUE/Monte Rosa Therapeutics, Inc.
Champoux Jennifer · Chief Operating Officer
Mechanical filing
AI thesis skipped - Jun 18, 2026·Form 4·Sell$57K
GLUE/Monte Rosa Therapeutics, Inc.
Townson Sharon · Chief Scientific Officer
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
GLUE/Monte Rosa Therapeutics, Inc.
Behbahani Ali · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
GLUE/Monte Rosa Therapeutics, Inc.
SCHIFF ANDREW N · director
Mechanical filing
AI thesis skipped - Jun 12, 2026·Form 4·Other—
GLUE/Monte Rosa Therapeutics, Inc.
Manning Anthony M. · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Sell$97K
GLUE/Monte Rosa Therapeutics, Inc.
Warmuth Markus · President & CEO
Mechanical filing
AI thesis skipped - Jun 1, 2026·Form 4·Sell$119.2K
GLUE/Monte Rosa Therapeutics, Inc.
Townson Sharon · Chief Scientific Officer
Mechanical filing
AI thesis skipped - May 28, 2026·Form 4·Sell$43.5K
GLUE/Monte Rosa Therapeutics, Inc.
Champoux Jennifer · Chief Operating Officer
Mechanical filing
AI thesis skipped - May 5, 2026·Form 4·Sell$103.4K
GLUE/Monte Rosa Therapeutics, Inc.
Warmuth Markus · President & CEO
Mechanical filing
AI thesis skipped